 |
|
Cold Supply Systems and Solutions 2012 (CSS) is focused on the current impact of the Good Distribution Practices guidelines concerning temperature regulated and/or temperature controlled products within the healthcare industry. The symposium covers all temperatures below zero as well as 2-to-8 and 15-to-25; ambient; you may download the agenda. |
 |
|
Management of corrective and preventative actions (CAPA) |
 |
|
Best practice approach in assessing stability data & the question of release |
ABOUT US
CSS2012 is a premier discussion designed with direct contribution and aid practitioners. Colleagues and experts engaged in both strategic and daily activities concerning temperature controlled products within the life science industry. CSS2012 is intended for professionals from the field concerned with expanding their knowledge base, learning and benchmarking from practical.The programme draws strength from addressing fundamentally difficult critical points through practical and new case studies. CSS2012 addresses the current GDP Guidelines (Draft), Emerging Markets and new ideas in relation to costs, quality and standardisation of processes. The case studies and topics are practical in nature and focused on current challenges and future trends. The symposium covers key drivers and inhibitors in relation to where the main focus will be within the next 12 to 18 months. All case studies are new and have been selected to address the forthcoming challenges within the industry.
World leading pharmaceutical companies present on the latest projects, and share key data concerning fail safe techniques and benchmarking. The case studies examine, assess and address the key challenges as well as success stories so a balanced argument concerning your current decisions can be taken away.
- Karin Froidbise, AFMPS, Senior Inspector GDP/GMP, Belgian Health Agency
- Martine Fitzgerald, Senior Legal Advisor GRIP, The European Association Of Pharmaceutical Wholesalers
- Dr B. Raveendran, Senior Director of Supply Chain and Distribution Merck, India
- Almut Malone, Clinical Shipments, Global Function, Bayer Healthcare
Current Attendees include end users from the pharmaceutical, biopharmaceutical and the healthcare industry in general. Colleagues from the regulatory bodies as well as suppliers and consultants who have join us to present and network concerning new and existing solutions.
Sample example of current attendees:
- Pfizer, Logistics manager
- Merck, Supply chain director
- Baxter, Quality assurance manager
- Johnson and Johnson, Transport manager
Hot Topics:
- Cold chain optimisation
- Good Distribution Practices
- Current GDP draft
- Emerging Market
- Risk mitigation and cost fail safe techniques
- Process harmonisation
- Cost and quality
Key Benefits for Attendance
- Over 15 ‘first time and new’ practical case studies
- Discuss a 24/7 cold chain monitoring
system - Learn what the inspector is looking for At length group discussions
- Acquire strength in your emerging-markets strategy
- Current regulatory update Network with you peers
